Skip to content

S. 526 · 118th Congress (2023–2025)

BENEFIT Act of 2023

This bill requires the Food and Drug Administration (FDA) to consider relevant patient experience data in the risk-benefit assessment framework used in the process for approving new drugs.

After a new drug application has been approved, the FDA's public statement about how it used patient experience data shall include a description of how such data was considered in the risk-benefit assessment framework.

Show official title

A bill to strengthen the use of patient-experience data within the benefit-risk framework for approval of new drugs.

Expired in Senate committee

Derived from the legislative history, not an official disposition.

Latest actionReferred to committee

This bill’s path

This is S. 526’s recorded path, not a universal congressional workflow.

How bills become lawAll actions
  1. Introduced

  2. Passed Senate

  3. Passed House

  4. Sent to President

  5. Signed into law

  6. Expired

Sponsor
Sen. Roger F. Wicker (R-MS)
Cosponsors
5 cosponsors

1 original · 4 later

  1. Sen. Amy Klobuchar (D-MN)· Original · Feb 16, 2023
  2. Sen. Susan M. Collins (R-ME)· Later · Mar 8, 2023
  3. Sen. Mike Braun (R-IN)· Later · Mar 28, 2023
  4. Sen. Rick Scott (R-FL)· Later · Oct 17, 2023
  5. Sen. Bill Hagerty (R-TN)· Later · Apr 30, 2024
Policy area
Health

On this page

Timeline

i

In chronological order. Major procedural acts are shown in full. Committee work and ordinary amendments fold in place where they happened, so they do not jump the sequence or stretch the timeline.

  1. Introduced in Senate

    Document: Introduced in Senate

    Sources
  2. Latest

    Referred to committee

    Read twice and referred to the Committee on Health, Education, Labor, and Pensions.

    Sources
  3. Expired

    Introduced → Referred to Senate Health, Education, Labor, and Pensions → No further action before the 118th Congress ended.

Committees

  1. SenateHealth, Education, Labor, and PensionsReferred Feb 16, 2023

Text & titles

i

Each distinct name Congress.gov recorded, once. Official, short, display, and popular titles stay distinct when the wording differs. The same wording is not repeated for every text version.

Text versions
VersionDateLinks
Introduced in Senate
Titles (3)
  1. BENEFIT Act of 2023

    Display title, Short title · Introduced in Senate

  2. Better Empowerment Now to Enhance Framework and Improve Treatments Act of 2023

    Short title · Introduced in Senate

  3. A bill to strengthen the use of patient-experience data within the benefit-risk framework for approval of new drugs.

    Official title · Introduced in Senate